Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date.

Antza C, Nirantharakumar K, Doundoulakis I, Tahrani AA, Toulis KA.

Drug Des Devel Ther. 2019 Aug 22;13:2985-2996. doi: 10.2147/DDDT.S166765. eCollection 2019.

2.

Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study.

Thayakaran R, Adderley NJ, Sainsbury C, Torlinska B, Boelaert K, Šumilo D, Price M, Thomas GN, Toulis KA, Nirantharakumar K.

BMJ. 2019 Sep 3;366:l4892. doi: 10.1136/bmj.l4892.

3.

Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis.

Lavrentaki A, Thomas T, Subramanian A, Valsamakis G, Thomas N, Toulis KA, Wang J, Daly B, Saravanan P, Sumilo D, Mastorakos G, Tahrani AA, Nirantharakumar K.

J Diabetes Complications. 2019 Oct;33(10):107401. doi: 10.1016/j.jdiacomp.2019.06.006. Epub 2019 Jun 27.

PMID:
31326267
4.

Correction: Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study.

Daly B, Toulis KA, Thomas N, Gokhale K, Martin J, Webber J, Keerthy D, Jolly K, Saravanan P, Nirantharakumar K.

PLoS Med. 2019 Jul 18;16(7):e1002881. doi: 10.1371/journal.pmed.1002881. eCollection 2019 Jul.

5.

Risk of incident circulatory disease in patients treated for differentiated thyroid carcinoma with no history of cardiovascular disease.

Toulis KA, Viola D, Gkoutos G, Keerthy D, Boelaert K, Nirantharakumar K.

Clin Endocrinol (Oxf). 2019 Aug;91(2):323-330. doi: 10.1111/cen.13990. Epub 2019 May 17.

PMID:
30993728
6.

Risk of Incident Obstructive Sleep Apnea Among Patients With Type 2 Diabetes.

Subramanian A, Adderley NJ, Tracy A, Taverner T, Hanif W, Toulis KA, Thomas GN, Tahrani AA, Nirantharakumar K.

Diabetes Care. 2019 May;42(5):954-963. doi: 10.2337/dc18-2004. Epub 2019 Mar 12.

PMID:
30862657
7.

Impact of glycaemic control on fracture risk in 5368 people with newly diagnosed Type 1 diabetes: a time-dependent analysis.

Thayakaran R, Perrins M, Gokhale KM, Kumaran S, Narendran P, Price MJ, Nirantharakumar K, Toulis KA.

Diabet Med. 2019 Aug;36(8):1013-1019. doi: 10.1111/dme.13945. Epub 2019 Apr 5.

PMID:
30848519
8.

Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study.

Balachandran K, Sumilo D, O'Reilly MW, Toulis KA, Gokhale K, Wijeyaratne C, Coomarasamy A, Arlt W, Tahrani A, Nirantharakumar K.

Eur J Endocrinol. 2019 Feb 1. pii: EJE-18-0693.R2. doi: 10.1530/EJE-18-0693. [Epub ahead of print]

9.

Recurrence in silent corticotroph adenomas after primary treatment: A systematic review and meta-analysis.

Fountas A, Lavrentaki A, Subramanian A, Toulis KA, Nirantharakumar K, Karavitaki N.

J Clin Endocrinol Metab. 2018 Dec 21. doi: 10.1210/jc.2018-01956. [Epub ahead of print]

PMID:
30590584
10.

Hypoglycaemia is associated with increased risk of fractures in patients with type 2 diabetes mellitus: a cohort study.

Ntouva A, Toulis KA, Keerthy D, Adderley NJ, Hanif W, Thayakaran R, Gokhale K, Thomas GN, Khunti K, Tahrani AA, Nirantharakumar K.

Eur J Endocrinol. 2019 Jan 1;180(1):51-58. doi: 10.1530/EJE-18-0458.

PMID:
30400051
11.

Discriminatory performance of adiponectin and leptin in the identification of impaired glucose tolerance: The Guangzhou Biobank Cohort Study - Cardiovascular Disease Subcohort.

Toulis KA, Jiang CQ, Hemming K, Nirantharakumar K, Cheng KK, Lam TH, Thomas GN.

PLoS One. 2018 Nov 6;13(11):e0206964. doi: 10.1371/journal.pone.0206964. eCollection 2018.

12.

Serum testosterone, sex hormone-binding globulin and sex-specific risk of incident type 2 diabetes in a retrospective primary care cohort.

O'Reilly MW, Glisic M, Kumarendran B, Subramanian A, Manolopoulos KN, Tahrani AA, Keerthy D, Muka T, Toulis KA, Hanif W, Thomas GN, Franco OH, Arlt W, Nirantharakumar K.

Clin Endocrinol (Oxf). 2019 Jan;90(1):145-154. doi: 10.1111/cen.13862. Epub 2018 Oct 23.

13.

Gestational dyslipidaemia and adverse birthweight outcomes: a systematic review and meta-analysis.

Wang J, Moore D, Subramanian A, Cheng KK, Toulis KA, Qiu X, Saravanan P, Price MJ, Nirantharakumar K.

Obes Rev. 2018 Sep;19(9):1256-1268. doi: 10.1111/obr.12693. Epub 2018 May 21.

PMID:
29786159
14.

Correction to: Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis.

Nirantharakumar K, Mohammed N, Toulis KA, Thomas GN, Narendran P.

Diabetologia. 2018 Jul;61(7):1688-1689. doi: 10.1007/s00125-018-4620-4. Epub 2018 Apr 25.

PMID:
29744540
15.

Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.

Kumarendran B, O'Reilly MW, Manolopoulos KN, Toulis KA, Gokhale KM, Sitch AJ, Wijeyaratne CN, Coomarasamy A, Arlt W, Nirantharakumar K.

PLoS Med. 2018 Mar 28;15(3):e1002542. doi: 10.1371/journal.pmed.1002542. eCollection 2018 Mar.

16.

Temporal and external validation of a prediction model for adverse outcomes among inpatients with diabetes.

Adderley NJ, Mallett S, Marshall T, Ghosh S, Rayman G, Bellary S, Coleman J, Akiboye F, Toulis KA, Nirantharakumar K.

Diabet Med. 2018 Jun;35(6):798-806. doi: 10.1111/dme.13612. Epub 2018 Mar 24.

PMID:
29485723
17.

Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis.

Nirantharakumar K, Mohammed N, Toulis KA, Thomas GN, Narendran P.

Diabetologia. 2018 May;61(5):1064-1070. doi: 10.1007/s00125-018-4574-6. Epub 2018 Feb 24. Erratum in: Diabetologia. 2018 Apr 25;:.

18.

Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study.

Daly B, Toulis KA, Thomas N, Gokhale K, Martin J, Webber J, Keerthy D, Jolly K, Saravanan P, Nirantharakumar K.

PLoS Med. 2018 Jan 16;15(1):e1002488. doi: 10.1371/journal.pmed.1002488. eCollection 2018 Jan. Erratum in: PLoS Med. 2019 Jul 18;16(7):e1002881.

19.

Initiation of dapagliflozin and treatment-emergent fractures.

Toulis KA, Bilezikian JP, Thomas GN, Hanif W, Kotsa K, Thayakaran R, Keerthy D, Tahrani AA, Nirantharakumar K.

Diabetes Obes Metab. 2018 Apr;20(4):1070-1074. doi: 10.1111/dom.13176. Epub 2018 Jan 8.

PMID:
29193543
20.

Males with prolactinoma are at increased risk of incident cardiovascular disease.

Toulis KA, Robbins T, Reddy N, Balachandran K, Gokhale K, Wijesinghe H, Cheng KK, Karavitaki N, Wass J, Nirantharakumar K.

Clin Endocrinol (Oxf). 2018 Jan;88(1):71-76. doi: 10.1111/cen.13498. Epub 2017 Nov 8.

PMID:
29044586

Supplemental Content

Loading ...
Support Center